COSM
Cosmos Health Inc. · Healthcare
0.31
0.91%(+0.00)
Prev. Close0.35
13.40%(+0.04)
Pre-marketLast Updated: — ET
52W L: $0.2852W H: $1.32
$0.32
CHG-0.05 (-12.42%)
H$0.42
L$0.28
VOL5.2M
COSM (1h)
Cosmos Health Inc. · Healthcare
Summit Therapeutics (NASDAQ: SMMT - Get Free Report) and Cosmos Health (NASDAQ: COSM - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Analyst Ratings This is a summary of current
Cosmos Health (NASDAQ: COSM - Get Free Report) and Profound Medical (NASDAQ: PROF - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings. Earnings and Valuation This table compares Cosmos
CHICAGO, IL / ACCESS Newswire / April 1, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that C-Scrub Wash 4%, manufactured by its wholly owned subsidiary Cana Laboratories S.A., has successfully completed testing under EN 12791:2016+A1:2017, the European standard for surgical hand disinfection.
Continues to deliver record revenue and improving operating metrics Significant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75% NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibility Evaluating potential monetization of non-core assets to support more efficient capital allocation accelerate strategic investments address the current valuation disconnect, including options such as share repurchases Recent geopolitical turmoil has had a negligible impact on the Company's operations, with record-breaking growth continuing at a strong pace To issue guidance update following the release of fourth quarter and full-year 2025 results Analyst coverage initiated by Zacks Small-Cap Research with a valuation of $4.50 per share CHICAGO, March 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today provided a corporate update and announced that it intends to issue updated operational, strategic, and financial guidance following the release of its fourth quarter and full-year 2025 financial results. Record Operating Momentum Cosmos Health continues to deliver record revenue and gross profit while improving operating metrics, reflecting disciplined execution across all core divisions.
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of Bitcoin as part of its ongoing digital assets treasury initiative. Following this purchase, Cosmos Health's total investment in digital assets has reached $3.1 million, reflecting the combined value of its holdings in Bitcoin and Ethereum.
CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has entered into a Letter of Intent (“LOI”), through its wholly owned subsidiary CosmoFarm S.A.
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
388,532 SH @ $0.37
2026-02-12
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
291,262 SH @ $0.41
2026-02-11
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
90,325 SH @ $0.50
2026-01-23
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
353,321 SH @ $0.50
2026-01-20
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
493,495 SH @ $0.45
2026-01-14
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
113,185 SH @ $0.50
2026-01-12
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
156,190 SH @ $0.52
2026-01-08
Siokas Grigorios
director, 10 percent owner, officer: Chief Executive Officer
124,880 SH @ $0.52
2026-01-07